NCT05633810View on ClinicalTrials.gov

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

PHASE3RecruitingINTERVENTIONAL
Enrollment

10,000

Participants

Timeline

Start Date

December 21, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Diabete Type 2Cardiovascular Diseases
Interventions
DRUG

Aspirin

40 mg non-enteric-coated tablet taken twice daily.

DRUG

Aspirin Placebo

non-enteric-coated tablet taken twice daily.

DRUG

Colchicine

0.5 mg tablet taken once daily

DRUG

Colchicine Placebo

tablet taken once daily.

Trial Locations (1)

Unknown

RECRUITING

Montreal Heart Institute, Montreal

All Listed Sponsors
lead

Montreal Heart Institute

OTHER